[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100614360":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":18,"responsibleParty":36,"collaborators":7,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":44,"eligibilityCriteria":45,"healthyVolunteers":40,"sex":46,"minAge":47,"maxAge":7,"enrollmentInfo":48,"targetDuration":7,"studyType":51,"phases":7,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"University Hospital, Clermont-Ferrand","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Clément RIOCREUX","PRINCIPAL_INVESTIGATOR",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Lise Laclautre","CONTACT","334.73.754.963","promo_interne_drci@chu-clermontferrand.fr",[19],{"facility":20,"status":21,"city":22,"state":7,"zip":7,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"CHU Clermont-Ferrand","RECRUITING","Clermont-Ferrand","France","FR",{"type":26,"coordinates":27},"Point",[28,29],3.08682,45.77969,{"lat":29,"lon":28},[32,35],{"name":10,"role":15,"phone":33,"phoneExt":7,"email":34},"0473752489","criocreux@chu-clermontferrand.fr",{"name":10,"role":11,"phone":7,"phoneExt":7,"email":7},{"type":37,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100614360","evaluation-of-heart-failure-telemonitoring-eligibility-criteria-100614360",false,"NCT07278583","Evaluation of Heart Failure Telemonitoring Eligibility Criteria","Evaluation of Eligibility Criteria for Heart Failure Telemonitoring : Analysis of CARDIAUVERGNE's Cohort","Weigh-HF","Inclusion Criteria:\n\n* adults\n* able to read and understand french\n* included in CARDIAUVERGNE telemonitoring program from 1st january 2023 to 31st december 2024 such as defined by the french health authorithy criteria (heart failure within 12 months or dyspnea at least NYHA 2 associated with NTproBNP of at least 1000pg\u002FmL) and excluded by medical decision as no longer presenting eligibillity criteria\n\nExclusion Criteria:\n\n* Patients leaving telemonitoring for other reasons (choice, death, medical reason, relocation, inobservance)","ALL","18 Years",{"count":49,"type":50},130,"ESTIMATED","OBSERVATIONAL","CARDIAUVERGNE is a heart failure telemonitoring system at Clermont-Ferrand's hospital. The aim of this study is to analyze the prognosis and evolution of patients after exclusion of telemonitoring. The patients were included from 1st January 2023 to 31st December 2024 and the monitoring was terminated for end of eligibility according to the French health authority criteria.",[54],"Heart Failure",[56,57],"heart failure","telemonitoring","2026-07-29",{"date":60,"type":61},"2026-07-30","ACTUAL",{"date":63,"type":61},"2025-12-05",{"date":65,"type":50},"2026-12",{"name":5,"class":6},1]